Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
Study sponsor: Imunon
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2013-01Actual
Enrollment · participants701Actual
Source updated2024-05-03Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.